Retrophin, Inc., announced that the US Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin), a new enteric─coated formulation of Thiola (tiopronin)
Latest articles
Nipocalimab Gets Fast-Tracked for Hemolytic Disease of the Fetus and Newborn
The Food and Drug Administration (FDA) has granted Fast Track designation to nipocalimab (M281) for the prevention of hemolytic disease of the fetus and newborn (HDFN). HDFN is a blood disorder that occurs during...
Smart Content Strategist Goes Way Beyond ‘Dummies’ for Salesforce (B2B CMY Finalist)
Heike Young creates content reflecting a research-driven, customer focus that fits in a cross-platform plan supported by employee engagement. Learn more about why this Salesforce content leader is a Content Marketer of...
New medical imaging device could help cut time and cost of procedures
Researchers have completed a successful clinical trial, managing to detect and image radioactive tracers used in PET and in SPECT scans at the same time, with the hope of enabling doctors to scan patients for...
AstraZeneca’s Lynparza scores limited NICE backing for new first-line maintenance use
With competitors racking up new indications and data wins, AstraZeneca’s Lynparza is looking to keep its lead in the PARP inhibitor field. England’s cost watchdog delivered a leg up Friday with a new recommendation—a...
Want to Scale Your Content Marketing? Get the Employees Involved
Every person has a story to tell. And if you are a smart content marketer, you know that every employee has a story that can sell your brand. If you want to scale your content marketing, you must look to the brand’s...
